␣-Cells were identified in preparations of dispersed mouse islets by immunofluorescence microscopy. A high fraction of ␣-cells correlated with a small cell size measured as the average cell diameter (10 µm) and whole-cell capacitance (<4 pF). The ␣-cells generated action potentials at a low frequency (1 Hz) in the absence of glucose. These action potentials were reversibly inhibited by elevation of the glucose concentration to 20 mmol/l. The action potentials originated from a membrane potential more negative than -50 mV, had a maximal upstroke velocity of 5 V/s, and peaked at +1 mV. Voltage-clamp experiments revealed the ionic conductances underlying the generation of action potentials. ␣-Cells are equipped with a delayed tetraethyl-ammonium-blockable outward current (activating at voltages above -20 mV), a large tetrodotoxin-sensitive Na + current (above -30 mV; peak current 200 pA at +10 mV), and a small Ca 2+ current (above -50 mV; peak current 30 pA at +10 mV). The latter flowed through -conotoxin GVIA (25%)-and nifedipine-sensitive (50%) Ca G lucagon is a major catabolic and hyperglycemic hormone of 29 amino acids and is secreted from the ␣-cells of the islets of Langerhans (1). Its main biological effect is the regulation of glucose metabolism by enhancing synthesis and mobilization of glucose in the liver. Normally, secretion of the hormone is stimulated by low blood glucose (2), amino acids (3), and a variety of hormones and neurotransmitters, such as adrenaline, glucose-dependent insulinotropic polypeptide, and glucagon-like peptide-1 (4,5). Hyperglycemia and fatty acids are the main inhibitors (6), but the islet hormones insulin and somatostatin (4) also appear to reduce glucagon secretion, possibly by a paracrine mechanism (7). Whereas insulin levels are inadequately low in hyperglycemic diabetic subjects, glucagon levels are actually elevated, and this increase exacerbates the disease (8). The reason for this abnormality is unknown, and studies on ␣-cells are complicated by the scarcity of islet tissue and the low occurrence of ␣-cells compared with -cells. Therefore, how glucose physiologically regulates secretion in the ␣-cell remains unknown. Electrical activity in glucagon-secreting cells has been observed using several experimental approaches (5,9,10), and it is, at least in part, attributable to voltage-gated Ca 2+ channels. Available evidence also suggests that glucagon release is a Ca 2+ -dependent process. Indeed, capacitance measurements on single rat ␣-cells revealed a close relationship between N-type Ca 2+ channels and the secretory granules under basal conditions, whereas L-type Ca 2+ channels appeared more important when secretion was stimulated with adrenaline (5). The finding that glucagon secretion is Ca 2+ -dependent, coupled with the fact that glucagon release is suppressed by glucose, suggests that the ␣-cells must be electrically silent at elevated glucose concentrations, contrary to the situation in the -cell. Thus, it is surprising that ATP-sensitive potassium channels (i.e...